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Renal agenesis in mice homozygous
for a gene trap mutation in the gene
encoding heparan
sulfate 2-sulfotransferase
Simon L. Bullock,1 Judy M. Fletcher,2 Rosa S.P. Beddington,1,4 and Valerie A. Wilson1,3
1Laboratory of Mammalian Development, Medical Research Council (MRC) National Institute for Medical Research,
The Ridgeway, London NW7 1AA, UK; 2MRC Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, UK;
3Molecular Medicine Centre, Western General Hospital, Edinburgh EH4 2XU, UK
Heparan sulfate proteoglycans have been implicated in the presentation of a number of secreted signaling
molecules to their signal-transducing receptors. We have characterized a gene trap mutation in the gene
encoding a heparan sulfate biosynthetic enzyme, heparan sulfate 2-sulfotransferase (HS2ST). Transgenic mice
were generated from embryonic stem cells harboring this insertion. lacZ reporter gene activity in
heterozygous embryos demonstrates that the gene is expressed differentially during embryogenesis,
presumably directing dynamic changes in heparan sulfate structure. Moreover, mice homozygous for the Hs2st
gene trap allele die in the neonatal period, exhibiting bilateral renal agenesis and defects of the eye and the
skeleton. Analysis of kidney development in Hs2st mutants reveals that the gene is not required for two early
events—ureteric bud outgrowth from the Wolffian duct and initial induction of Pax-2 expression in the
metanephric mesenchyme. It is required, however, for mesenchymal condensation around the ureteric bud
and initiation of branching morphogenesis. Because 2-O-sulfation has been shown to influence the functional
interactions of ligands with heparan sulfate in vitro, we discuss the possibility that the Hs2st mutant
phenotype is a consequence of compromised interactions between growth factors and their signal-transducing
receptors. These data provide the first genetic evidence that the regulated synthesis of differentially
glycosylated proteoglycans can affect morphogenesis during vertebrate development.
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Heparan sulfate proteoglycans (HSPGs) are expressed at
the surface of most animal cells, where they interact
with a variety of proteins, including extracellular matrix
components, growth factors, degradative enzymes, and
protease inhibitors (for review, see Bernfield et al. 1992).
Heparin-like molecules have been implicated in the pre-
sentation of a number of secreted signaling molecules,
such as members of the fibroblast growth factor (FGF),
Wingless/Wnt, transforming growth factor-b (TGF-b)
and Hedgehog families (Rapraeger et al. 1991; Yayon et
al. 1991; Lee et al. 1994; Reichsman et al. 1996; Ruppert
et al. 1996; Binari et al. 1997), to their signal-transducing
receptors. In some cell types, there is an obligate require-
ment for cell-surface HSPGs in the FGF-signaling path-
way leading to the proposal that these molecules func-
tion as low-affinity receptors facilitating the interaction
of ligands with high-affinity receptor tyrosine kinases
(Klagsbrun and Baird 1991; Yayon et al. 1991; Schless-
inger et al. 1995). In addition, HSPGs may bind growth
factors in the extracellular matrix, altering their stabil-
ity and modulating their effective concentration (Saksela
and Rifkin 1990; Reichsman et al 1996).
The specificity of HSPG–ligand interactions resides, at
least in part, in the structure of the heparan sulfate gly-
cosaminoglycan side chains, which vary in number,
length, sequence composition, and sulfation pattern be-
tween cell type and developmental stage (Gallagher et al.
1986; Nurcombe et al. 1993; Kato et al. 1994). Therefore,
the regulated synthesis of differentially glycosylated pro-
teoglycans may represent an additional means to regu-
late cell–cell communication during development.
In a gene trap screen designed to identify genes impor-
tant in mouse embryogenesis, we recovered an integra-
tion into the gene encoding heparan sulfate 2-sulfotrans-
ferase (HS2ST). This enzyme catalyzes the transfer of
sulfate to position 2 of the iduronic acid component of
heparan sulfate (Kobayashi et al. 1997). We show that
Hs2st is expressed differentially during embryogenesis,
presumably reflecting changes in the proteoglycan side
chain structure. Moreover, mice homozygous for the
gene trap mutation exhibit bilateral renal agenesis, re-
sulting from a failure of ureteric bud branching and mes-
enchymal condensation, and defects of the eye and skel-
eton. These data provide the first genetic demonstration
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of heparan sulfate function in vertebrate embryonic de-
velopment.
Results
ST125 represented one embryonic stem (ES) cell line se-
lected from a gene trap screen designed to identify inte-
grations into genes encoding secreted or transmembrane
proteins expressed during early organogenesis (Skarnes
et al. 1995; see Materials and Methods). Expression of the
lacZ reporter was demonstrated in mid-gestation chime-
ras (data not shown) and subsequently adult chimeras
were generated to transmit the integration through the
germ line and establish a line of mice heterozygous for
the gene trap allele (designated Hs2stTgNSt125Nimr). These
heterozygotes were viable and fertile, displaying no overt
defects by 18 months of age.
Characterization of ST125 insertion site
58 RACE was used to clone a portion of the trapped gene
from the ST125 cell line, which proved to be the previ-
ously unidentified mouse homolog of hamster Hs2st.
The protein product of this gene catalyzes the transfer of
sulfate from 38-phosphoadenosine 58-phosphosulfate to
position 2 of L-iduronic acid in heparan sulfate. The gene
has been cloned recently from Chinese hamster ovary
(CHO) cells (Kobayashi et al. 1997) and the protein was
predicted to be localized to the Golgi in a type II mem-
brane orientation.
A probe corresponding to the ST125 58 RACE product
was used to isolate a 2.1-kb mouse Hs2st clone from a
8.5-day postcoitum (d.p.c.) mouse embryo cDNA library.
In addition, the same probe was used to isolate a Xeno-
pus homolog of Hs2st from a gastrula-stage cDNA li-
brary using low-stringency screening. Sequence analysis
demonstrated that the protein product of Hs2st is highly
conserved in vertebrates, sharing 99% and 90% amino
acid sequence identity with its hamster and Xenopus
homologs, respectively (Fig. 1A). Furthermore, the
mouse protein shares 58% amino acid sequence identity
over a 245-amino-acid region with the predicted protein
product of the Drosophila melanogaster S1 cDNA. The
function of the S1 gene is unknown but it was identified
as a candidate gene for the Sd mutation associated with
the Segregation distorter meiotic drive system (Powers
and Ganetzky 1991). Interestingly, one highly conserved
block of sequence present in vertebrate HS2STs dis-
played significant homology with a large number of en-
zymes that catalyze the transfer of sulfate to a variety of
molecules (Fig. 1B). This suggests that this region may be
important for the catalytic mechanism although it is ab-
sent from some sulfotransferases, including heparan sul-
fate N-deacetylase/N-sulfotransferase (Hashimoto et al.
1992). It would, however, be present in the fusion protein
generated by the gene trap insertion (Fig. 1A).
ST125 comprises a single gene trap insertion that
disrupts the Hs2st transcript
FISH analysis to G-banded metaphase spreads of ST125
ES cells (Fig. 1C) revealed that Hs2st maps to a subtelo-
meric location on chromosome 3 (3H). Furthermore,
only a single gene trap vector insertion site was evident,
localized to chromosome 3, and it coincided precisely
with the position of Hs2st (Fig. 1C). Molecular charac-
terization of the mutant allele revealed a single copy of
the gene trap vector and restriction mapping of genomic
DNA and PCR-amplified flanking regions revealed no
microdeletions or rearrangements within 10 kb on either
side of the insertion site (data not shown). FISH analysis
was also used to show that a genomic human HS2ST
sequence hybridized to human chromosome 1p31 (Fig.
1D), a region showing synteny with mouse chromosome
3H (DeBry and Seldin 1996). The human HS2ST map
position was refined further by radiation hybrid mapping
to 3.87cR from D1S2167 on chromosome 1.
The junction in the 58 RACE product of the endog-
enous mouse sequence and the gene trap vector splice
acceptor sequence predicted that amino acid residues
carboxy-terminal to position 196, including several re-
gions with a high degree of evolutionary conservation,
would not be encoded by the gene trap allele (Figs. 1A
and 2A). Given the recessive nature of the Hs2st mutant
phenotype (see below) the gene trap insertion is likely to
cause a loss-of-function mutation; however, we cannot
state categorically that it is a null allele.
Northern hybridization was performed on RNA iso-
lated from wild-type, heterozygous, and homozygous
embryos generated by intercrossing heterozygotes. Em-
bryos were genotyped using a PCR-based assay that dis-
tinguished between the wild-type and the gene trap al-
lele (see Materials and Methods). This analysis revealed
that Hs2st transcripts were disrupted by the gene trap
integration (Fig. 2B). Using a probe specific to the 58
RACE product, a transcript of 2.4 kb was detected in
RNA derived from wild-type, but not from homozygous,
mutant embryos. In the latter, only a 5.6-kb band (the
size predicted for the gene trap fusion mRNA) was ob-
served and no wild-type transcript could be detected.
Heterozygotes were found to possess the wild-type and
fusion transcripts in equal amounts. Low levels of a 4-kb
transcript, possibly representing an alternative splice prod-
uct, were present in wild-type RNA but were undetect-
able in homozygous mutant RNA, indicating that this
transcript was also disrupted by the transgene insertion.
Embryonic expression pattern of Hs2st
The lacZ expression pattern in heterozygous embryos
was examined at various developmental stages (Fig. 3).
At 7.5 d.p.c., all three germ layers expressed lacZ, al-
though there appeared to be elevated expression in the
embryonic ectoderm and the node (Fig. 3A). Widespread
expression persisted at 8.5 d.p.c., although b-gal activity
was clearly stronger in rhombomeres 2 and 4 and bran-
chial arches 1 and 2 (which are populated by neural crest
from these rhombomeres) (Fig. 3B,C). At 10.5 d.p.c., the
dorsal and ventral aspects of the neural tube, brain, and
midbrain–hindbrain junction showed the most intense
staining (Fig. 3D,E). A day later in development, elevated
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b-gal activity was found in the floor plate (Fig. 3F,G) and
the sclerotome (data not shown). At 12.5 d.p.c., both the
floor plate (data not shown) and the roofplate exhibited
strong lacZ staining as did the mesenchyme of the limb
and of the developing whisker follicles (Fig. 3H). At 13.5
d.p.c., lacZ expression predominated in embryonic mes-
enchyme, especially at sites of epithelial–mesenchymal
interactions such as the developing teeth (data not
shown) and whisker follicles (Fig. 3I). Strong staining
was also apparent in the perichondria of the cartilagi-
nous skeleton (Fig. 3J), an important site for the regula-
tion of skeletal differentiation (Vortkamp et al. 1996).
b-gal activity in Hs2st+/− embryos faithfully reflected
the endogenous gene expression pattern as revealed by in
situ hybridization using an antisense Hs2st probe (Fig.
3B,D,F; data not shown).
Hs2st is required for metanephric development
Genotype analysis of prenatal litters between 8.5 and
15.5 d.p.c. indicated that there was no significant death
of homozygotes before the latter stages of gestation [73
homozygotes (27%) identified out of a total of 273 em-
bryos]. Homozygous mutants, however, were either still-
born or died within 24 hr of birth and showed bilateral
renal agenesis. This completely penetrant phenotype
(Table 1; Fig. 4) was probably responsible for the neonatal
lethality. No abnormalities were observed in other parts
of the urogenital system (Fig. 4) or in other internal or-
gans. All heterozygotes and wild types examined had
overtly normal kidneys.
In amniotes, the permanent (or metanephric) kidney is
formed by the interaction of two mesodermal deriva-
Figure 1. Characterization of the ST125 insertion site. (A) Alignment of deduced amino acid sequence of mouse Hs2st cDNA with
those of hamster and Xenopus Hs2st and Drosophila S1 cDNAs. Identical residues are boxed in black. The published carboxy-terminal
52 amino acids of Drosophila S1 are excluded on the basis of new sequence data (C. Merrill and B. Ganetzky, pers. comm.). (Arrow)
Position of gene trap vector insertion site. Residues carboxy-terminal to this site are not predicted to be encoded by the gene trap allele.
The conserved block sharing homology with several sulfotransferases is boxed in red. (B) Partial alignment of hamster HS2ST
(GenBank protein accession no. 2196446) with human phenol sulfotransferase (accession no. 1711607), rat minoxidil sulfotransferase
(accession no. 310179), rat dopamine-tyrosine sulfotransferase (accession no. 1711584), human thyroid hormone sulfotransferase
(accession no. 2290540), rat N-hydroxyarylamine sulfotransferase (accession no. 1711569), rat estrogen sulfotransferase (accession no.
1711599), mouse alcohol sulfotransferase (accession no. 1711587), Flaveria bidentis flavonol-3-sulfotransferase (accession no.
1706738), chick chondroitin-6-sulfotranferase (accession no. 2494838), Drosophila S1 (accession no. 11013), and the predicted protein
product of a human EST (GenBank nucleotide accession no. AA334103). Identical residues are shaded in black, conservative changes
are shaded in gray. (C) Metaphase spread of ST125 ES cells subjected to fluorescent in situ hybridization with a probe specific to the
mouse Hs2st genomic sequence (green) and a probe specific to the gene trap vector (red). Areas of overlap between the two signals are
yellow. Chromosomes were counterstained with DAPI (blue). Hybridizing chromosomes were classified as chromosome 3, using
Quips Karyotyper (data not shown). In 15 spreads, no other chromosome consistently gave a signal. (D) FISH to metaphase spread from
human blood, using a human HS2ST genomic fragment as a probe. Both copies of chromosome 1p3 show hybridization (green spots).
In 10 spreads no other chromosome consistently gave a signal.
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tives, the epithelial ureteric bud and the metanephric
mesenchyme. At 10.75 d.p.c. in the mouse, the ureteric
bud emerges from the Wolffian (or nephric) duct, thereby
contacting the adjacent metanephric mesenchyme. The
metanephric mesenchyme induces the ureteric bud to
elongate and branch repeatedly, ultimately forming the
collecting duct system and, at the same time, the ure-
teric bud tips prevent the metanephric mesenchyme
from undergoing apoptosis and induce it to condense,
epithelialize, and differentiate into secretory nephrons
(Grobstein 1953; for review, see Bard et al. 1996; Vainio
and Mu¨ller 1997).
To investigate the embryological basis of the renal de-
fect, the developing kidneys of Hs2st−/− mutants were
compared with those of normal littermates. At 11.5
d.p.c., all wild-type and heterozygous kidney rudiments
examined (n = 85, where n = number of kidneys exam-
ined) contained a ureteric bud that had bifurcated once
or, less frequently, twice, and was surrounded by a
mantle of mesenchymal condensation (Fig. 4C,E). In con-
trast, Hs2st−/− kidney rudiments (n = 48) contained an
unbranched ureteric bud that was not surrounded by
condensed metanephric mesenchyme (Fig. 4D,F). In ho-
mozygous mutants at 12.5 d.p.c., no branching of the
ureteric bud had occurred and there were no overt signs
of mesenchymal condensation (data not shown; n = 44),
demonstrating that renal development was arrested
rather than delayed. Therefore, Hs2st is not required for
the initial outgrowth of the ureteric bud from the Wolf-
fian duct but rather for ureteric bud branching and mes-
enchymal condensation. The presence of relatively long
unbranched ureters in neonatal Hs2st−/− mutants (Fig.
4B) shows that the gene is not required for the directional
growth of this tissue.
Expression of Hs2st during kidney development
In heterozygotes at 10.75 d.p.c., weak b-gal activity was
evident in the metanephric mesenchyme, Wolffian duct,
and emergent ureteric bud (Fig. 5A). At 11.5 d.p.c., re-
Figure 2. Hs2st transcripts are disrupted by the gene trap in-
sertion. (A) Schematic of mouse Hs2st cDNA showing position
of gene trap vector insertion site. The shaded box represents a
1068-bp ORF; the integration site corresponds to position 588
(start of translation = position 1). (SA) Splice acceptor; (TM)
transmembrane-encoding region. (B) Northern hybridization of
10 µg of total RNA isolated from a wild-type (+/+), a heterozy-
gote (+/−), and a homozygous mutant (−/−) 15.5-d.p.c. embryo
using a probe specific to the ST125 58 RACE product. The weak
4-kb signal (asterisk) detected in the wild-type RNA may rep-
resent an endogenous unprocessed Hs2st RNA or splice variant
that is disrupted in the mutants and is represented too poorly in
a heterozygote RNA population to be visualized. b-Actin was
used as a loading control.
Figure 3. Expression pattern of Hs2st re-
vealed by lacZ reporter activity in hetero-
zygous embryos (A,C,E,G,H,I,J) and whole-
mount in situ hybridization with an anti-
sense Hs2st probe (B,D,F). (A) A 7.5-d.p.c.
sagittal section of a late headfold stage em-
bryo (anterior to the left) showing wide-
spread b-gal activity, with elevated levels
in the node (arrow) and embryonic ecto-
derm (arrowhead). (B,C) An 8.5 d.p.c., lat-
eral view of 12 somite embryos. Wide-
spread expression persists, but there is el-
evated b-gal activity in rhombomeres 2 and
4 (arrowheads). (D,E) Lateral view of a 10.0-
d.p.c. embryo showing elevated expression
in the roof plate (black arrowhead), floor
plate (white arrowhead), and midbrain–
hindbrain junction (arrow). (F,G) Trans-
verse section through an 11.5-d.p.c. embryo. Strong expression is exhibited by the floor plate (arrow). (H) A 12.5-d.p.c. lateral view. The
roof plate (red arrow), telencephalic vesicles (red arrowhead), vibrissa follicles (black arrow), and limb mesenchyme (black arrowhead)
express high levels of lacZ. (I) Transverse section through a 13.5-d.p.c. embryo showing vibrissa follicle expression localized to the
mesenchyme (arrowheads) and the developing hairshaft (arrow). (J) Sagittal section through a 14.5-d.p.c. embryo, dorsal to the left.
Reporter gene activity is associated with the perichondria surrounding the ribs (arrowheads). Scale bar in J: 125 µm (A); 425 µm (B,C);
1000 µm (D,E); 150 µm (F,G); 1800 µm (H); 500 µm (I); 375 µm (J).
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porter gene expression was almost undetectable in the
ureteric bud epithelium; in contrast, the metanephric
mesenchyme expressed high levels of lacZ (Fig. 5B). To
follow Hs2st expression during subsequent metanephric
development, 11.5-d.p.c. Hs2st+/− kidney rudiments
were cultured in vitro (Fig. 5C,D). After 24 hr of culture,
lacZ was no longer expressed in the ureteric bud. Strong
b-gal activity, however, was apparent throughout the
metanephric mesenchyme with the exception of matur-
ing mesenchymal aggregates around the ureteric bud
tips. Therefore, it would appear that Hs2st expression is
rapidly down-regulated as the mesenchyme starts to dif-
ferentiate. In 96-hr cultures, b-gal activity persisted in
undifferentiated mesenchyme but was not evident in
any of the maturing components of the kidney. This mir-
rored the situation in vivo; lacZ-expressing cells were
localized to the mesenchyme at the periphery of the 14.5
d.p.c. Hs2st+/− kidney, where new nephric tubules were
being induced (Fig. 5E). These data do not distinguish
whether the primary defect in kidney development in
homozygous mutants resides in the metanephric mesen-
chyme itself or stems from a very early defect in the
nascent ureteric bud.
Expression of molecular markers for metanephric
development in Hs2st mutants
Whole-mount in situ hybridization and immunohisto-
chemistry was used to assay the expression of well-char-
acterized markers of metanephric development in mu-
tant embryos (Fig. 6). For each marker at each stage,
a minimum of five and, in most cases, more than 12
mutant kidneys where compared with a similar number
of heterozygous and wild-type littermates. The tran-
scription factor Pax-2 , as well as being expressed in the
Wolffian duct, mesonephric tubules, and the ureteric
bud epithelium, is induced in the metanephric mesen-
chyme following interaction with the ureteric bud
(Dressler et al. 1990). In Hs2st−/− urogenital systems at
11.5 and 12.5 d.p.c., Pax-2 expression in the Wolffian
duct and the mesonephric tubules was identical to that
seen in the normal situation. In the kidneys, however,
only an unbranched Pax-2-expressing ureteric bud was
present. At 12.5 d.p.c., wild-type and heterozygous kid-
neys contained a number of Pax-2-expressing mesenchy-
mal aggregates surrounding branching ureteric bud tips
(Fig. 6C). In contrast, in homozygous mutant mesen-
chyme there was only a relatively small patch of Pax-2-
expressing cells, which were located at some distance
from the ureteric bud tip. It has been observed in vitro
that, once induced, metanephric mesenchymal cells
move away from the inducing tissue, thereby facilitating
the induction of further mesenchyme (Saxe´n and Karki-
inen-Ja¨a¨skela¨inen 1975). Because mutants one day ear-
lier in development (11.5 d.p.c.) did have Pax-2-express-
ing mesenchymal cells adjacent to the unbranched ure-
teric bud (Fig. 6B), it is likely that the paucity of cells
expressing this protein at 12.5 d.p.c., and their remote-
ness from the ureteric bud, reflects an early transient
signal between the ureteric bud and metanephric mes-
enchyme.
The Ret receptor tyrosine kinase and its ligand glial
cell line-derived neurotrophic factor (GDNF) are compo-
nents of a signaling pathway required for ureteric bud
outgrowth from the Wolffian duct and collecting duct
morphogenesis (Schuchardt et al. 1994, 1996; Durbec et
al. 1996; Moore et al. 1996; Pichel et al. 1996; Sa´nchez et













no. examined 29/29 12/29 16*/29 5/29
a(*) Of which, 13 had an extra digit on the right forelimb.
Figure 4. Bilateral renal agenesis in Hs2st mutant mice and its
embryological basis. Dissected urogenital systems of normal
(heterozygous) (A) and homozygous mutant (B) newborn mice.
Homozygotes display bilateral renal agenesis and possess a
blind-ended ureter (ur). The remainder of the mutant urogenital
system is normal. (ad) Adrenal gland; (b) bladder; (ki) kidney; (o)
ovary. (C–F) Morphology of representative 11.5-d.p.c. heterozy-
gous (C,E) and mutant (D,F) embryonic kidney rudiments
viewed in whole-mount (lateral view) (C,D) or as 8 µm-trans-
verse sections stained with haematoxylin and eosin (E,F). (C) In
heterozygotes, the ureteric bud has invaded the mesenchyme
and bifurcated once to form a T-shape surrounded by a mantle
of condensed mesenchyme (double-headed arrow). (D) In mu-
tants, the ureteric bud has emerged from the Wolffian duct and
invaded the mesenchymal blastema but failed to bifurcate and
there are no overt signs of mesenchymal condensation. In C and
D the position of the ureteric bud tip(s) is highlighted by red
dots. (E) A dilated ureteric bud (arrowheads) is present in the
heterozygotes surrounded by condensed mesenchyme. (F) In
mutants, the ureteric bud (arrowhead) has not dilated, and there
are no overt signs of condensation in the mesenchyme. (Arrow
in E and F) Wolffian duct. Scale bar in F, 1300 µm (A and B); 30
µm (C–F).
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al. 1996; Trupp et al. 1996). In homozygotes, as in wild-
type and heterozygous embryos, Gdnf transcripts were
present in the uninduced metanephric mesenchyme at
10.75 d.p.c. (data not shown). Later, Gdnf is normally
highly expressed in mesenchymal cells surrounding the
ureteric bud tips (Fig. 6D,F; Durbec et al. 1996). In
Hs2st−/− kidneys, Gdnf expression was attenuated at
11.5 d.p.c. (Fig. 6E) and undetectable by 12.5 d.p.c. (Fig.
6F). In homozygous, heterozygous, and wild-type em-
bryos, c-ret was expressed along the length of the Wolf-
fian duct and in the emergent ureteric bud at 10.75 d.p.c.
(data not shown). As the ureteric bud elongated and
branched in heterozygous and wild-type embryos, c-ret
expression resolved to the tips of branching ureteric buds
(Fig. 6G). In Hs2st−/− embryos the unbranched ureteric
bud tips at 11.5 d.p.c. showed only low levels of c-ret
expression (Fig. 6H) and this expression had disappeared
24 hr later (Fig. 6I). Therefore, following invasion of the
metanephric mesenchyme by the ureteric bud, Hs2st ap-
pears to be required for maintenance of Gdnf expression
and the localization of c-ret expression to the ureteric
bud tip. Likewise, expression of Wnt11 in ureteric bud
tips, which is compromized in vitro by inhibitors of gly-
cosaminoglycan synthesis (Kispert et al. 1996), was not
detected within the ureteric bud tip in Hs2st mutants
following invasion of the metanephric mesenchyme (Fig.
6K). The maintenance of apparently normal levels of ex-
pression within the ureter of markers such as Sox9 (Fig.
6L; Kent et al. 1996) and Pax-2 (see above) in mutants
indicates that Hs2st is not required for ureter identity
but for maintenance of expression of genes associated
specifically with branching ureteric bud tips.
Skeletal and eye defects in Hs2st mutants
As well as the kidney phenotype, other defects were ap-
parent in homozygous mutants (Table 1; Fig. 7). There
was a global increase in bone mineralization in homozy-
gotes (Fig. 7B,C) and ectopic ossification of the sternum
(six of seven mutants examined; Fig. 7E) and fusions of
the cervical vertebrae (two of seven mutants examined;
data not shown) occurred. In addition, a high frequency
of mutants exhibited post-axial polydactyly and interest-
ingly this predominated in the right forelimb. A cleft of
the secondary palate was also a frequent occurrence
(Table 1). Bilateral coloboma of the iris, resulting from a
perturbation of pigmented retinal epithelium differentia-
tion, was seen in 14/14 homozygotes examined (Fig. 7E).
Histological sections revealed that mutants showed
signs of retardation in eye development (data not shown).
Furthermore, six of eight mutant animals had cataracts
(data not shown). The expression pattern of Hs2st is con-
sistent with a role in the development of the skeleton
and the eye. The gene is highly expressed in the peri-
chondria during skeletogenesis (Fig. 3J) and at the junc-
tion of the neural and pigmented retinal epithelia during
development of the eye (data not shown). No gross ana-
tomical defects were evident in the brain and spinal cord,
although a more detailed analysis may reveal subtle de-
fects.
Discussion
Attribution of the mutant phenotype to the gene trap
insertion in Hs2st
We have characterized a gene trap mutation in the gene-
encoding heparan sulfate 2-sulfotransferase. We find that
mice homozygous for this mutation die in the neonatal
period and invariably exhibit bilateral renal agenesis and
defects of the eye and skeleton. Cleft palate and polydac-
tyly also occur with incomplete penetrance.
The consistent segregation of the mutant phenotype
with homozygosity for the unique gene trap insertion
in Hs2st strongly suggests that it is disruption of this
gene that is responsible for the lesions observed. More-
over, Hs2st is expressed in all tissues showing overt
abnormalities and no intact Hs2st transcripts are de-
Figure 5. Hs2st expression during kidney development re-
vealed by lacZ reporter activity in heterozygous tissue. (A)
Transverse section through a 10.75-d.p.c. embryo. Weak b-gal
activity is detected in the metanephric mesenchyme (black ar-
rowheads), ureteric bud epithelium (arrow), and the Wolffian
duct (red arrowhead). (B) Transverse section through an 11.5-
d.p.c. embryo showing b-gal activity in the kidneys specific to
the metanephric mesenchyme (arrowheads). Expression is ab-
sent from the ureteric bud (arrows). Kidney rudiments (11.5
d.p.c.) were cultured for 24 hr (C) or 96 hr (D) before X-gal stain-
ing. (C) Expression is restricted to the undifferentiated meta-
nephric mesenchyme (black arrowheads) and is absent from the
ureteric bud system (black arrows), and mesenchymal aggre-
gates (white arrows). (D) Expression is localized to undifferen-
tiated mesenchyme at the periphery of the culture (arrowheads).
(E) Section through a 14.5-d.p.c. embryo showing weak b-gal
activity in mesenchyme at the periphery of the kidney (arrow-
heads) where new nephric tubules are being induced. Scale bar,
100 µm (A–C); 200 µm (D,E).
Role of Hs2st in kidney development
GENES & DEVELOPMENT 1899
tected in RNA derived from homozygous embryos. The
gene trap allele is predicted to encode a fusion pro-
tein with the highly conserved endogenous carboxy-
terminal 160 amino acids (out of a total of 356) replaced
with a b-galactosidase–neomycin phosphotransferase
fusion. This is likely to constitute a null allele, but final
proof requires a detailed biochemical analysis of sul-
fation status of heparan sulfate chains in mutant tis-
sues.
Several documented human disorders involve abnor-
malities of the kidney, eye, skeleton, and palate (Online
Mendelian Inheritance in Man, http://www3.ncbi.
nlm.nih.gov/omim). No human genetic disorders with
defects reminiscent of the murine phenotype, however,
have yet been associated with human chromosome
1p31, where we have shown that HS2ST maps. Likewise,
there are no classical mouse mutations resembling the
Hs2st−/− phenotype, which map to mouse chromo-
some 3H.
HSPGs can influence signaling interactions
The HS2ST enzymatic activity characterized in CHO
cells catalyzes 2-O-sulfation of L-iduronic acid in hepa-
ran sulfate but is thought not to transfer sulfate to other
glycosaminoglycan substrates, such as dermatan sulfate,
keratan sulfate, and chondroitin sulfate (Kobayashi et al.
1996, 1997). Therefore it is predicted that the Hs2st−/−
mutant phenotype stems largely or exclusively from de-
fects in heparan sulfate molecules. Deficiency in 2-O-
sulfation may be accompanied by a secondary increase in
N-sulfated glucosamine residues in heparan sulfate and
altered degradation products (Bai and Esko 1996; Bai et
al. 1997), and some of these modifications may have ad-
ditional biological significance. Several biochemical and
Figure 6. Expression of molecular markers for
metanephric development in Hs2st mutants in
dissected 11.5-d.p.c. kidney rudiments (A,B,
D,E,G,H) and 12.5-d.p.c. urogenital regions
(C,F,I,L). Heterozygous (+/−) or wild-type (+/+)
(A,D,G,J and left-hand specimen in C,F,I,L) and
homozygous mutant (−/−) (B,E,H,K and right-
hand specimen in C,F,I,L) specimens subjected to
immunostaining with anti-Pax-2 antibody (A–C)
or whole-mount in situ hybridization with probes
specific to Gdnf (D–F), c-ret (G–I), Wnt11 (J,K), or
Sox9 (L). Kidney rudiments are labeled with black
arrowheads in C, F, I, and L. (A) At 11.5 d.p.c,
Pax-2-positive cells are abundant in the meta-
nephric mesenchyme surrounding the ureteric
bud, which also expresses Pax-2 and has bifur-
cated twice. (B) In mutants at 11.5 d.p.c., Pax-2
expression is detected in the unbranched ureter
(black arrow) and in the mesenchyme concen-
trated in a small population of cells at a distance
from the ureteric bud tip. Note the ‘‘stream’’ of
Pax-2-positive cells adjacent to the bud tip (white
arrow). (C) At 12.5 d.p.c., Pax-2 expression is lo-
calized to the mesonephric tubules (mt), Wolffian
ducts (wd), and ureteric epithelium in mutant and
heterozygous or wild-type urogenital systems.
Mutants have unbranched Pax-2-expressing ure-
ters (white arrowheads) and possess few Pax-2
positive cells in the mesenchyme (black arrow-
heads). (D) At 11.5 d.p.c., strong Gdnf expression
is detected in the mesenchyme surrounding the
bifurcated ureteric bud. (E) In mutants, Gdnf ex-
pression in mesenchyme adjacent to the un-
branched ureteric bud is attenuated (black arrow).
(F) In 12.5-d.p.c. Hs2st mutant kidney rudiments, Gdnf transcripts are no longer detected. (G) At 11.5 d.p.c., c-ret transcripts are
detectable throughout the ureteric bud (black arrow) and are abundant in the ureteric bud tips. (H) In mutants at 11.5 d.p.c., c-ret
expression in the ureteric bud is comparable to wild-type or heterozygous kidneys, but strong expression is not detected in the
unbranched ureteric bud tip (black arrow). (I) At 12.5 d.p.c., c-ret transcripts are abundant in the bifurcated ureteric bud tips of the
heterozygous or wild-type kidney and are no longer detectable in mutant kidney rudiments. (J) At 11.5 d.p.c., Wnt11 is expressed in
ureteric bud tips and in mesenchyme proximal to the Wolffian duct (arrow). (K) In mutants, Wnt11 expression is undetectable in the
unbranched ureteric bud (position highlighted by black dots). (L) In heterozygous or wild-type kidneys at 12.5 d.p.c., Sox9 transcripts
are detected in the ureteric system. In mutants, expression persists at apparently normal levels in the unbranched ureter (white
arrowheads). Black arrows show expression of Sox9 in the male gonads [the mutant urogenital region is female and, therefore, does
not express Sox9 in the gonad (Kent et al. 1996; Morais da Silva et al. 1996)]. Scale bar in L: 100 µm (A,B,D,E,G,H,J,K); 800 µm
(C,F,I,L).
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in vitro studies have shown that 2-O-sulfation in par-
ticular is essential if heparan sulfate is to interact with
certain growth factors such as FGF-2 (basic FGF; Turn-
bull et al. 1992; Maccarana et al. 1993; Bai and Esko
1996). This modification appears not to be required for
the interaction of hepatocyte growth factor with its re-
ceptor (Lyon et al. 1994). Therefore, modulating the lev-
els of 2-O-sulfation may confer an additional level of
specificity on some, but not all, growth factor–receptor
interactions. HSPG structure varies extensively between
tissues during development (Bernfield et al. 1992), and
one means of achieving this diversity is illustrated here
by the regulated expression of Hs2st. Several embryonic
signaling centres, such as the node and floor plate, show
elevated expression of the gene, and there is a clear ex-
ample of its apparent down-regulation on epithelializa-
tion of the metanephric mesenchyme.
There is increasing evidence that HSPGs can modulate
the activity of growth factors through a number of
mechanisms, including facilitating their dimerization or
altering their effective concentration by acting as low-
affinity receptors (Schlessinger et al. 1995). Recently, ge-
netic studies in Drosophila have demonstrated a role for
heparin-like glycosaminoglycans in the reception of the
Wingless (Wg) signal (Binari et al. 1997; Ha¨cker et al.
1997; Haerry et al. 1997). Embryos that are either defi-
cient in an enzyme catalyzing the production of a gly-
cosaminoglycan precursor or that have been treated with
an enzyme that specifically degrades heparan gly-
cosaminoglycans, exhibit phenotypes reminiscent of
loss-of-Wingless signaling. It has also been suggested
that changes in HSPG expression may influence the dis-
tance over which a morphogen such as Wg can act; re-
stricting it to a short-range signal in some circumstances
but allowing it to serve as a more widespread gradient
morphogen in others (Ha¨cker et al. 1997). Therefore, it is
likely that modulating the sulfation status of HSPGs
will influence the availability of critical ligands and it is
tempting to speculate that the Hs2st−/− phenotype is
due, at least in part, to the suboptimal presentation of
signaling molecules to their receptors.
Consequences of the Hs2st mutation
Previous experiments on early kidney development in
vitro showed that the somewhat indiscriminate inhibi-
tion of de novo glycosaminoglycan sulfation by chlorate
reversibly blocks ureteric bud growth and branching but
does not affect nephrogenesis (Davies et al. 1995). The
phenotype observed in Hs2st−/− mutants, however, indi-
cates an earlier requirement for 2-O-sulfation in the ini-
tial condensation of the metanephric mesenchyme. Dur-
ing collecting duct morphogenesis, Hs2st does not seem
to be required for the initial outgrowth of the ureteric
bud from the Wolffian duct but rather for its subsequent
branching following contact with the metanephric mes-
enchyme. This suggests that it is required downstream
of genes such as Wt1, Pax2, c-ret, and Gdnf (Kreidberg et
al. 1993; Schuchardt et al. 1994, 1996; Torres et al. 1995;
Moore et al. 1996; Pichel et al. 1996; Sanchez et al. 1996),
which are implicated in ureteric bud outgrowth, but up-
stream of other genes such as Wnt4 and Bmp7 that are
necessary for normal nephrogenesis (Stark et al. 1994;
Dudley et al. 1995; Luo et al. 1995).
Interestingly, the metanephric phenotype of mice ho-
mozygous for a mutation in the homeobox gene Emx2,
which is expressed in the ureteric bud (Miyamoto et al.
1997), is strikingly similar to that of Hs2st−/−. In both
mutants, kidney development is arrested at the same
stage and both show a very consistent phenotype, unlike
the variability seen in Gdnf and c-ret mutants, which
ranges from complete absence of ureteric bud to the
development of small kidneys (Schuchardt et al. 1994;
Moore et al. 1996). This suggests that there may be
additional signaling mechanisms involving molecules
other than Ret and GDNF that are regulated by Emx2 in
the ureteric bud and require the mediation of HSPGs.
FGF-2 can substitute for the ureteric bud to induce
mesenchymal condensation and prevent apoptosis in
cultured metanephric mesenchyme (Perantoni et al.
1995). Interestingly, FGF-2 stimulates growth and inhib-
its differentiation of chondrocytes (Suzuki 1992) and this
effect is likely to depend on the presence of sulfated gly-
cosaminoglycans as their removal by chlorate promotes
chondrocyte differentiation (Chintala et al. 1995). There-
fore, impaired FGF-2 signaling could explain many of the
defects observed in Hs2st−/− mutants. Mice homozygous
for a null mutation in Fgf2, however, show no overt de-
fects in kidney morphogenesis or skeletogenesis (R.
Figure 7. Defects of the skeleton and the eye in newborn Hs2st
mutants. (A–D) Alcian blue-alizarin red skeletal preparations of
wild-type (A, D, and left-hand specimen in C) and Hs2st mutant
(B, D, and right-hand specimen in C) newborn mice (ossified
tissue, red; cartilage, blue). Compared with wild types (A),
Hs2st−/− mice (B) exhibit skeletal abnormalities associated with
increased bone mineralization. Note proximal shortening and
increased girth of the long bones in mutants. (C) Wild-type and
mutant scapulae. Note increased girth in the mutant. (D,E)
Comparison of mutant and wild-type rib cages. In the wild type
(D), costal cartilage crosses the sternum. In mutants (E), the
sternum is fused. Additional patterning abnormalities are often
observed (arrow). Note the decreased width of the mutant rib
cage. (F) Comparison of mutant and wild-type eyes. Hs2st mu-
tants exhibit iris colobomas associated with defective pig-
mented epithelium differentiation.
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Dono and R. Zeller, pers. comm.) demonstrating that
simple failure of FGF-2 signaling is not an adequate ex-
planation for the Hs2st mutant phenotype. Because
other members of the FGF family are expressed in the
developing kidney (Finch et al. 1995), the phenotype ob-
served in Hs2st−/− embryos may be attributable to per-
turbation of more than one FGF-signaling pathway.
Cells expressing a vertebrate wg homolog Wnt1 can
induce tubulogenesis in isolated metanephric mesen-
chyme (Herzlinger et al. 1994). Wnt1, however, is not
itself expressed in the embryonic kidney, indicating that
other Wnt family members may normally be responsible
for early inductive events in metanephric development.
The expression of Wnt4 is consistent with such a role
although it appears to be required later than Hs2st. The
metanephric mesenchyme of Wnt4−/− mutants does con-
dense but fails to transform into an epithelium (Stark et
al. 1994). Wnt11 is expressed at the ureteric bud tips and
therefore it may contribute to mesenchymal induction
(Kispert et al. 1996). If so, its signaling, like that of Wg in
Drosophila, may be compromized in the absence of ap-
propriately sulfated HSPGs.
It is also possible that failure to undergo changes in
adhesion could contribute to the Hs2st−/− phenotype.
HSPGs can interact with a variety of matrix components
via their heparan–sulfate chains, including certain colla-
gens, tenascin, thrombospondin, and fibronectin and can
be concentrated in focal adhesions (for review, see Bern-
field et al. 1992; Woods and Couchman 1994). Clearly
metanephric mesenchymal condensation requires alter-
ations in adhesive properties and defective sulfation
might prevent such changes. The transmembrane HSPG
Syndecan-1 can regulate cell adhesion and cell morphol-
ogy (Leppa¨ et al. 1992) and is up-regulated dramatically
in the metanephric mesenchyme on induction (Vainio et
al. 1989). Therefore, it is possible that its function is
compromized by the Hs2st mutation. At present, the
potential roles of Hs2st in modulating signaling and ad-
hesive properties cannot be distinguished and it is pos-
sible that both are important in kidney development.
Late onset and restricted pattern of phenotype
It is intriguing, considering the gene’s widespread early
expression, that Hs2st is not essential for early embryo-
genesis and that certain tissues that express Hs2st later
in development, such as the lungs and teeth (data not
shown), appear to develop normally in the mutants. Al-
though it is possible that 2-O-sulfation is only required
in the developing kidney, skeleton, and eye it is more
likely that in other tissues and organs HS2ST function
may be compensated for by other sulfotransferases. It has
been suggested, based on biochemical experiments, that
there may be more than one type of 2-O-sulfotransferase
activity (Wlad et al. 1993). Moreover, a human EST dis-
tinct from the human homolog of Hs2st shows greater
similarity to Hs2st than to any other sulfotransferase
(Fig. 1B; unpubl.). Therefore the phenotype of Hs2st−/−
embryos may reflect those sites where HS2ST is the only
2-O-sulfation enzyme expressed.
Materials and methods
Production of gene trap ES cells
Electroporation and selection of CGR8 (129/Ola) ES cells was
performed as described (Skarnes et al. 1995). The vector
pGTtm0 was a gift from W. Skarnes and forms fusion proteins
in a different open reading frame (ORF) to the parent plasmid
pGT1.8TM (Skarnes et al. 1995). The vector contains a splice
acceptor sequence upstream of CD4 transmembrane domain
sequence, a lacZ–neomycin phosphotransferase fusion (b-geo)
and a polyadenylation signal such that integrations into introns
of transcriptionally active genes will produce a b-galactosidase
(b-gal) fusion protein that contains endogenous sequence
amino-terminal to the site of insertion. The inclusion of a trans-
membrane domain-encoding region in the vector enriches for
insertions downstream of secretory signal sequences or type II
transmembrane domains because b-gal activity is only pre-
served when the enzyme is retained in the cytoplasm (Skarnes
et al. 1995).
The vector was electroporated into 1 × 108 CGR8 ES cells.
Colonies (149) resistant to G418 were recovered and 39 (26%) of
these exhibited b-gal activity. In 16 of these clones, b-gal activ-
ity showed a subcellular localization typical of fusion with a
secreted or transmembrane protein (Skarnes et al. 1995). Chi-
meras were generated from these cells and the ES cell line
ST125 was one integration selected for further analysis on the
basis that lacZ reporter gene expression was evident in 8.5- and
9.5-d.p.c. chimeric embryos.
Rapid amplification of cDNA ends
Total RNA was isolated from the ST125 cell line using the
guanidinium thiocyanate method (Chomczynski and Sacchi
1987). cDNA was synthesized from 5 µg of total RNA and
58 rapid amplification of cDNA ends (RACE) performed using
the Marathon cDNA amplification kit (Clontech) according
to manufacturer’s instructions. Following adaptor ligation,
35 cycles of PCR were conducted using Marathon adaptor
primer 1 (58-CCATCCTAATACGACTCACTATAGGGC-38)
and a primer specific to the CD4 transmembrane domain region
(58-TGAAGGGTGAGTGGGAGCGTTT-38). A 1/50 dilution of
the PCR products was subjected to 30 cycles of nested PCR
[adaptor primer 2 (58-ACTCACTATAGGGCTCGAGCGGC-
38), CD4 primer 2 (58-AGTAGACTTCTGCACAGACACC-38)]
and gene trap RACE products verified using Southern blotting
and hybridization with an end-labeled oligonucleotide probe
specific for the En-2 exon sequence in the gene trap vector (58-
GTCCCAGGTCCCGAAAACCAAAGAAGAAGAACG-38) us-
ing standard procedures. Following size-selection of hybridizing
products (Quiaex II Gel Extraction Kit, Quiagen), NotI–PstI-di-
gested fragments were cloned into pSPORT1 (GIBCO–BRL).
Plasmids harboring gene trap products were identified using a
diagnostic BglII–SmaI digest followed by manual DNA sequenc-
ing (U.S. Biochemical Manual Sequencing Kit). The BLAST al-
gorithm (Altshul et al. 1990) was used to search the databases
for sequence homologies.
Isolation of cDNA and genomic clones
PCR employing primers specific to the ST125 58 RACE prod-
uct (58-GCAGGATGCAACTCTGGATG-38 and 58-GCCTCT-
CAATAGGGTCCCTGAT-38) was used to amplify a 319-bp
probe, termed ST125A, which was used to screen a 8.5-d.p.c.
mouse embryo cDNA lGT10 library (Farhner et al. 1987) using
standard procedures. Two independent clones representing full-
length Hs2st cDNAs were isolated. The same probe was used to
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isolate bacteriophage l clones harboring genomic DNA inserts
corresponding to the mouse Hs2st gene from a CGR8 ES cell
lKO genomic library (Nehls et al. 1994) and the human HS2ST
gene from a human fibrosarcoma cell line genomic lDASHII
library [Stratagene; hybridization: 0.5 M phosphate buffer
(pH7.2), 7% SDS, 1mM EDTA at 50°C for 16 hr; Washes: 2×
SSC/0.1% SDS at 50°C, 3 times]. Xenopus laevis Hs2st cDNAs
were isolated from an amplified gastrula cDNA library in Uni-
ZAP XR (Cho et al. 1991) using low-stringency screening. Filters
were hybridized with the mouse ST125A probe in 30% form-
amide, 5× SSC, 5× Denhardt’s solution, 0.02% NaPP, 0.1% SDS,
0.1 mg/ml of yeast tRNA, 0.03 M phosphate buffer (pH 6.5) at
37°C and washed in 2× SSC/0.1% SDS 3 times at 37°C.
FISH and karyotyping
Metaphase chromosome spreads were made from ST125 ES
cells or human blood lymphocyte preparations using standard
procedures (Robertson 1987). To determine the localization of
Hs2st and the gene trap insertion, Giemsa banding was carried
out (Klever et al. 1991) and 15 spreads from each of two slides
were recorded as digital images using Quips Capture software
(Vysis) along with their position on the slide. One slide was
hybridized to a 12-kb mouse genomic Hs2st probe, and the other
to a gene trap vector-specific probe. Chromosomes showing hy-
bridization on the captured spreads were compared with the
corresponding Giemsa-banded image. The chromosome was
identified by karyotyping using Quips Karyotyper software (Vy-
sis). This analysis additionally confirmed the absence of cyto-
genetically visible chromosome anomalies. A similar procedure
was used to identify the chromosomal localization of human
HS2ST, using a 16-kb human genomic probe. To show colocal-
ization of the gene trap vector insertion with mouse Hs2st in
ST125 cells, double FISH was carried out (Fantes et al. 1995)
using a digoxigenin-labeled Hs2st probe and a biotinylated gene
trap vector probe.
Radiation hybrid mapping
An intron-specific portion of human HS2ST was subcloned and
the sequence used to design primers that specifically amplified
a 101-bp PCR fragment from human, but not hamster DNA
(58-TGTGAACCATGTTAGCCA-38, 58-TGAAATCAAAAGA-
TGCTG-38). These were used to screen the GeneBridge 4 hu-
man–hamster radiation hybrid panel (Gyapay et al. 1996). Data
were submitted to the Human Genome Mapping Project and
mapped using the Whitehead Institute statistical program RH-
MAPPER.
ES cell chimeras and transgenic mice
Mice were maintained on a 10-hr light, 14-hr dark cycle. Noon
on the day of finding a vaginal plug was designated 0.5 d.p.c.
Germ-line mice were generated by injection of ST125 ES cells
into C57/BL6 blastocysts followed by transfer to a foster
mother (Hogan et al. 1994). Chimeric male mice were mated to
C57/BL6 females and F1 progeny analyzed for the presence of
the transgene. Heterozygous animals were backcrossed onto a
C57/BL6 background and heterozygous siblings intercrossed.
Recovery of embryos and lacZ expression pattern analysis
Embryos were dissected from the uterus in M2 medium con-
taining 10% fetal bovine serum (Advanced Protein Products) as
described (Hogan et al. 1994) and X-gal-stained overnight ac-
cording to the method of Beddington et al. (1989). In all cases,
transgenic samples were incubated with stage-matched wild-
type tissues to control against endogenous b-gal activity. Ex
vivo kidney cultures were performed as described before stain-
ing (Kispert et al. 1996).
Genotyping procedures
Hs2st+/− mice could be distinguished from wild-type littermates
by X-gal staining of tail biopsies. To establish an allele-specific
genotyping assay, Hs2st genomic sequences flanking the vector
insertion site were amplified from lacZ-positive genomic DNA
(High-fidelity PCR system; Boehringer Mannheim), cloned and
sequenced. Subsequently, PCR primers were designed such that
a common primer, specific to sequences 58 to the insertion (58-
ATCAATGAATAATTGCCTAGGTC-38) was used in conjunc-
tion with a primer specific to sequences 38 to the insertion
(58-GGGAAGAAATTCACCCCAACA-38) and a primer that
recognizes sequences in the gene trap vector (58-TACTCAGT-
GCAGTGCAGTCA-38) to generate 344- and 174-bp products
specific to the mutant and wild-type alleles, respectively. Ge-
nomic DNA (500 ng) was denatured at 94°C for 5 min and
immediately transferred to ice before amplification in a 20-µl
reaction volume [0.6 µM each primer, 50 mM KCl, 10 mM
Tris-HCl (pH 8.3), 1 mM MgCl2, 100 µM dNTPs, 1 unit of Am-
plitaq (Perkin-Elmer)], to 30 cycles (94°C for 20 sec, 60°C for 30
sec, 72°C for 30 sec) and a single elongation step (72°C for 5
min).
Northern hybridization
Total RNA was isolated from individual 15.5-d.p.c. embryos
recovered from an intercross of heterozygous Hs2st+/− parents
using the method of Chomczynski and Sacchi (1987), following
harvesting of yolk sacs for DNA genotyping. Total RNA (10 µg)
from embryos of each genotype was electrophoresed in a 1.5%
formaldehyde–agarose gel as described (Sambrook et al. 1989)
and transferred to Hybond N membrane (Amersham) according
to manufacturer’s instructions. The membrane was hybridized
at 65°C with the ST125A probe in 5× Denhardt’s, 4× SSC, 50
mM NaH2PO4, 10% dextran sulfate and washed in 0.5× SSC/
0.1% SDS and then 0.2× SSC/0.1% SDS at 65°C before autora-
diography. The membrane was reprobed with a b-actin cDNA
probe (Harrison et al. 1995).
Whole-mount in situ hybridization
and immunohistochemistry
Whole-mount in situ hybridization was performed as described
(Wilkinson 1992) with two modifications. Urogenital ridges
were treated for 30 min in 20 µg/ml proteinase K (as opposed to
15 min in 10 µg/ml for embryos and dissected kidneys) and, in
all cases, embryo powder was omitted from the procedure. Di-
goxigenin-labeled antisense riboprobes were generated as de-
scribed previously for Gdnf and c-ret (Durbec et al. 1996),
Wnt11 (Kispert et al. 1996), and Sox9 (Morais da Silva et al.
1996). The Hs2st antisense riboprobe was transcribed from a
cDNA clone representing amino acids 8–330.
For whole-mount immunohistochemistry, urogenital ridges
were fixed in 4% PFA for 15 min, washed once in PBS contain-
ing 1% Triton X-100 and several times in PBS containing 0.1%
Triton X-100. Following an overnight incubation at 4°C in a
1:400 dilution of anti-Pax-2 IgG (Dressler and Douglass 1992) in
PBS, Pax-2 expression was detected using a horseradish peroxi-
dase (HRP)-conjugated goat anti-rabbit IgG secondary antibody
(Sigma Immunochemicals) as described (Kispert and Herrman
1994).
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Skeletal preparations and histochemistry
Skeletal preparations of newborn mice were made using an al-
cian blue–alizarin red method as described (Kessel and Gruss
1991) and hematoxylin and eosin staining was performed ac-
cording to Kaufman (1992).
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